See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $463B | 7.6x | 18.1x | |
| $361B | 4.2x | 15.2x | |
| $236B | 4.6x | 19.2x | |
| $173B | 2.5x | 11.7x | |
| $76.1B | 1.4x | 6.8x | |
| $70.1B | 3.5x | 14.2x | |
| $64.7B | 3.4x | 12.3x | |
| $60.2B | 8.4x | 36.4x | |
| $53.2B | 3.6x | 14.4x | |
| $49.8B | 9.7x | 42.0x | |
| $45.1B | 3.1x | 21.4x | |
| $43.9B | 4.7x | 19.3x | |
| $40.4B | 2.7x | 12.0x | |
| $32.8B | 1.4x | 7.5x | |
| $29.0B | 2.4x | 16.0x | |
| $22.5B | 2.2x | 6.3x | |
| $22.2B | 3.6x | 15.8x | |
| $22.0B | 1.5x | 8.1x | |
| $20.6B | 1.8x | 10.3x | |
| $17.8B | 1.6x | 10.9x | |
| $13.1B | 7.7x | 37.5x | |
| $12.3B | 2.1x | 14.3x | |
| $11.3B | 2.0x | 9.6x | |
| $10.7B | 6.9x | 27.6x | |
| $10.5B | 7.5x | 41.4x | |
| $9.7B | 6.7x | 35.7x | |
| $8.2B | 1.3x | 7.6x | |
| $7.5B | 1.2x | 13.7x | |
| $7.2B | 1.2x | 6.9x | |
| $6.4B | 6.8x | 26.6x | |
| $6.4B | 9.5x | 29.6x | |
| $6.2B | 2.9x | 16.6x | |
| $5.6B | 3.7x | 18.5x | |
| $5.1B | 1.2x | 6.9x | |
| $4.9B | 1.7x | 11.4x | |
| $4.6B | 10.7x | 32.7x | |
| $4.5B | 1.6x | 6.8x | |
| $4.5B | 9.2x | 35.9x | |
| $4.4B | 3.6x | 22.8x | |
| $4.3B | 1.3x | 7.5x | |
| $4.0B | 4.4x | 10.7x | |
| $3.8B | 3.4x | 10.5x | |
| $3.6B | 1.1x | 7.1x | |
| $3.4B | 2.1x | 11.6x | |
| $3.3B | 1.6x | 9.5x | |
| $3.0B | 1.5x | 10.5x | |
| $3.0B | 9.0x | 33.8x | |
| $3.0B | 0.6x | 5.4x | |
| $2.7B | 1.8x | 9.0x | |
| $2.6B | 0.7x | 4.9x | |
| $2.6B | 2.5x | 11.1x | |
| $2.6B | 3.2x | 15.9x | |
| $2.5B | 0.9x | 7.4x | |
| $2.5B | 5.7x | 21.5x | |
| $2.3B | 1.0x | 5.0x | |
| $2.3B | 0.5x | 6.6x | |
| $2.1B | 5.6x | 16.3x | |
| $2.0B | 2.6x | 18.4x | |
| $2.0B | 0.9x | 6.5x | |
| $1.9B | 3.4x | 16.9x | |
| $1.8B | 1.7x | 12.1x | |
| $1.7B | 6.6x | 18.3x | |
| $1.7B | 1.1x | 9.0x | |
| $1.7B | 2.4x | 11.8x | |
| $1.7B | 2.5x | 11.6x | |
| $1.7B | 0.9x | 7.1x | |
| $1.6B | 1.4x | -19.3x | |
| $1.4B | 0.7x | 7.4x | |
| $1.4B | 1.1x | 7.9x | |
| $1.4B | 0.8x | 6.3x | |
| $1.3B | 0.6x | 5.7x | |
| $1.3B | 1.8x | 7.3x | |
| $1.0B | 8.1x | 30.3x | |
| $1.0B | 1.4x | 9.7x | |
| $948M | 3.8x | 57.3x | |
| $914M | 0.8x | 7.7x | |
| $900M | 2.1x | 9.5x | |
| $830M | 1.8x | 8.8x | |
| $798M | 1.0x | 5.3x | |
| $743M | n/a | n/a | |
| $685M | 0.2x | 1.6x | |
| $671M | n/a | n/a | |
| $598M | 0.9x | 6.8x | |
| $560M | 1.4x | 8.3x | |
| $555M | 1.9x | -28.2x | |
| $540M | n/a | n/a | |
| $525M | 0.3x | n/a | |
| $508M | n/a | n/a | |
| $481M | 1.8x | 20.7x | |
| $368M | 1.8x | -32.0x | |
| $352M | n/a | n/a | |
| $346M | 0.8x | 10.1x | |
| $346M | 1.2x | 9.6x | |
| $328M | 1.3x | n/a | |
| $309M | n/a | n/a | |
| $247M | 0.7x | 11.1x | |
| $217M | 4.3x | 16.4x | |
| $214M | 1.5x | 6.5x | |
| $206M | 2.5x | 14.6x | |
| $198M | 0.4x | 11.5x | |
| $196M | n/a | n/a | |
| $188M | 0.9x | 4.1x | |
| $172M | 0.9x | 8.4x | |
| $169M | n/a | n/a | |
| $156M | 0.8x | n/a | |
| $151M | 0.6x | 6.3x | |
| $144M | n/a | n/a | |
| $138M | 2.3x | 8.3x | |
| $129M | 0.5x | 5.9x | |
| $89.7M | 0.8x | 846.1x | |
| $84.5M | n/a | n/a | |
| $69.8M | 0.3x | 6.9x | |
| $47.7M | 1.8x | 7.7x | |
| $42.2M | n/a | n/a | |
| $41.5M | n/a | n/a | |
| $39.7M | n/a | n/a | |
| $39.0M | n/a | n/a | |
| $35.9M | 2.8x | n/a | |
| $34.0M | 0.8x | n/a | |
| $29.1M | n/a | n/a | |
| $17.5M | n/a | n/a | |
| $16.5M | n/a | n/a | |
| $14.1M | 0.7x | -8.4x | |
| $13.0M | n/a | n/a | |
| $6.0M | n/a | n/a | |
| $2.0M | n/a | n/a | |
| $1.4M | n/a | n/a | |
| -$41.7M | -0.1x | -11.7x | |
| -$61.0M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty